Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

September 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • SARS-CoV-2: CAN INCORPORATE THEIR GENOME IN THE HOST CELL

What if a beetle could detect regional biodiversity?

Bioengineered hybrid scaffold makes muscle regeneration possible

SARS-CoV-2: CAN INCORPORATE THEIR GENOME IN THE HOST CELL
  • BiotechToday
  • World

SARS-CoV-2: CAN INCORPORATE THEIR GENOME IN THE HOST CELL

bioxone February 25, 2021February 25, 2021

PRAGYA SANTRA, AMITY UNIVERSITY

COVID-19 drastically hit 2020, an eye-witnessed pandemic for us all. Analysis from many patients suffering from COVID-19 the second time suggests that the immune system failed to ward off the second thrash of the virus. A recent study now puts light on the fact. Reports highlight that the coronavirus mutates itself masking in the form of HIV and other retroviruses integrating its genetic code into the patient’s chromosome but don’t become permanent genetic residence in the human cells. Though all viruses insert their genetic strain in the host cells but don’t incorporate them in the host’s DNA. Once the viruses successfully create maximum infection to the host,  they go off. 

For confirmation of the new research, PCR is performed. Specific virus sequences in fragmented form were detected in the biological samples of nasal swabs. For further assurance of whether the fragmented virus genome could replicate within the host cells, the researchers added reverse transcriptase (RT) (enzyme converting RNA into DNA) to human cells. They performed two types of experiments. In the first experiment RT gene from HIV was added and in the second RT using LINE-1 elements (remnants of previous retroviral infections with 17% of the human genome) are added. Cells preparing either form of the enzymes converted a few SARS-CoV-2 RNA to DNA incorporating them into the host chromosome. This can further lead to enhance the toxicity within the patient’s body but only if the full genome is replicated and is incorporated in the human chromosome, not the fragmented part. In such cases, even the host immune system fails to recognize the causative pathogens at times for being they are replicating in the host cell itself along with the human chromosomes.

This kind of integration is extremely rare. LINE-1 elements in human remain rarely active. Though still more new researches are in processing for more solid pieces of evidence. But if this phenomenon becomes true then many patients will go unrecognized even by PCR analysis which will mislead the COVID treatment.

Also read:What if a beetle could detect regional biodiversity?

SOURCE: The coronavirus may sometimes slip its genetic material into human chromosomes—but what does that mean; Jon Cohen; Health Science; Dec. 16, 2020; doi:http://doi.org/10.1126/science.abg2000

SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome; Liguo Zhang, Alexsia Richards et al; bioRxiv; 13 December 2020; Volume: 12, Issue: 12 Pg. no: 422516; doi: https://doi.org/10.1101/2020.12.12.422516

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged chromosome COVID-19 DNA human genome immune system LINE-1 PCR retrovirus reverse transcriptase RNA viral genome

One thought on “SARS-CoV-2: CAN INCORPORATE THEIR GENOME IN THE HOST CELL”

  1. Pingback: Bioengineered hybrid scaffold makes muscle regeneration possible - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Bioengineered hybrid scaffold makes muscle regeneration possible

bioxone February 26, 2021

Sristi Raj Rai, Amity University Kolkata The soft tissue that has the potential to produce a force that helps in voluntary/involuntary body movements is called muscle. The motion is a result of sliding movements of actin and myosin, the two protein filaments that help muscle contract. There are 3 types of muscles: skeletal (bone), cardiac […]

muscle regeneration

Related Post

  • BiotechToday
  • World

Type 2 Diabetes can be triggered by Prolonged Use of Common Acid Reflux Drugs

bioxone September 30, 2020September 30, 2020

-Team bioXone Research by an international team of scientists suggested that regular use of proton pump inhibitors (PPIs), commonly used to treat acid reflux, are related to a heightened risk of developing type 2 diabetes. The results also indicated that with the duration of PPI use, this risk of type 2 diabetes increases; prompting the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • Job and Internship
  • Signaling Pathway
  • World

CIAB Fellowships For Biotech & Microbiology | Applications Invited

bioxone March 8, 2021March 7, 2021

-Shristi Sharma, Team bioXone CIAB Fellowships For Biotech & Microbiology – Applications Invited. Center of Innovative and Applied Bioprocessing (CIAB) Mohali is recruiting for govt job vacancies. MSc/Ph.D./BTech Biotechnology & Microbiology candidates from various backgrounds are encouraged to attend the walk-in as per the details below: CIAB Vacancy Details CENTER OF INNOVATIVE AND APPLIED BIOPROCESSING […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Molnupiravir: The real game-changer for COVID-19?

bioxone March 20, 2021March 20, 2021

Shagufta Hasan, Amity University Kolkata  The world has had hard knocks with COVID-19 vaccines but no drug seems to give full coverage against the virus, but now, it may hope for good news. A new drug, Molnupiravir, has been developed by Merck & Co. Inc in association with Ridgeback Biotherapeutics, a biotechnology company, focused on […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy